Intellectual Property Issues and Strategies for the Marijuana Industry

(549 Ratings)

Produced on: April 21, 2017

Course Format On Demand Audio

Taught by

Categories:

Course Description

Time 61 minutes
Difficulty Advanced

This seminar, taught by Dean Fanelli, Partner at Seyfarth Shaw in Washington D.C., provides a detailed analysis of the current state of intellectual property laws in the United States as they relate to the protection of cannabis and the cannabis industry.

The program focuses on the background and potential policy shifts toward enforcement of marijuana laws under the current administration, how intellectual property rights as they relate to cannabis and the cannabis industry are protected and enforced in the United States, the future of the cannabis industry, and strategy tips for cannabis companies to protect their intellectual property.

Learning Objectives:

  1. Understand how the cannabis industry is and is not protected by intellectual property laws
  2. Identify the effect of uneven state legalization and federal enforcement on advising cannabis industry clients on intellectual property claims
  3. Learn best practices for enforcing intellectual property for cannabis products

Faculty

Dean Fanelli

Seyfarth Shaw LLP

Dean L. Fanelli, Ph.D.  is a partner in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington D.C. office.  Dr. Fanelli’s practice focuses on the chemical, pharmaceutical, and biotechnology industries and his expertise lies in patent portfolio creation and management, counseling, technology transactions, due diligence, opinion work, including drafting novelty, freedom-to-operate, and invalidity opinions, and inter partes review and post grant review proceedings.

Dr. Fanelli’s focus is on pharmaceutical and chemical related technologies including those in the fields of new chemical entities, pharmaceutical formulations, polymers, diagnostics, and medical devices.  Dr. Fanelli also has significant experience with the interplay between patent and FDA laws under the Hatch-Waxman Act, and he regularly handles IP issues attendant to mergers, acquisitions, and financing for life sciences companies as well as ANDA analyses and associated Hatch-Waxman Paragraph IV litigation.

Previously, Dr. Fanelli was a Founding Partner and Chair of Fanelli Haag PLLC.  Fanelli Haag joined Seyfarth Shaw LLP in October 2016. Fanelli Haag was a leading intellectual property boutique law firm focused on issues facing the biotechnology, pharmaceutical, and chemical industries.  In 2015, Corporate Counsel ranked Fanelli Haag as a “Most-Favored IP Boutique — One of the Best Firms in IP,” according to a report from BTI Consulting Group.  CorporateINTL Magazine named Fanelli Haag “2016 Biotech Patent Law Firm of the Year” in Washington, D.C. Additionally, Fanelli Haag was named ACQ Global Legal Awards' 2016 “Game Changer of the Year” in Washington, D.C.

Dr. Fanelli has firsthand experience in translating technologies into a successful commercial ventures.  While at Fanelli Haag, Dr. Fanelli was a co-founder of PhosImmune, Inc., an immuno-oncology neoantigen discovery startup company co-founded and built by Fanelli Haag and ultimately acquired by Agenus, Inc. (NASDAQ: AGEN) in December 2015.  In addition, Dr. Fanelli has developed various patent portfolios for commercially relevant products including those directed to:  Dificid® (fidaxomicin), which is currently marketed for the treatment of infections related to C. difficile, and Nexterone® (amiodarone HCl), marketed for the treatment and prophylaxis of ventricular fibrillation.  

Prior to founding Fanelli Haag, Dr. Fanelli was in private practice in the Washington D.C. offices of two international law firms, where his work focused primarily on patent prosecution and counseling of clients in the pharmaceutical, chemical, cosmetic and nutritional industries.  Dr. Fanelli also has expertise with medical products, chemical compounds, polymer compositions, food additives and cosmetic compositions. 

Dr. Fanelli gained additional experience in strategic patent management and licensing while working in-house with an international pharmaceutical drug-delivery company and while working in-house with a major consumer product company.

Dr. Fanelli actively participates in the American Intellectual Property Law Association (AIPLA), American Bar Association and American Chemical Society.  He is also a member of AIPLA‘s Intellectual Property Practice in Japan Committee. Dr. Fanelli’s articles have been published in peer-reviewed scientific journals, and he has given presentations and published articles on various topics related to intellectual property.

Education

  • J.D., The George Washington University Law School

  • Ph.D., Organic Chemistry, Temple University

  • B.S., Chemistry, Villanova University

Admissions

  • District of Columbia
  • New York
  • Registered Patent Attorney, U.S. Patent and Trademark Office

Courts

  • United States Supreme Court


Reviews

JC
Jeffrey C.

Thank you.

MB
Mark B.

Interesting content and well presented.

JS
Joanna S.

Very informative. Sound practical advice.

NT
Nora T.

Good presentation.

GG
Gerald G.

Feeling irie

PV
Paul V.

Awesome class.

SL
Susan L.

this program was useful in the District of Columbia

RD
Renee D.

Great course. Learned a lot- Thanks!

PS
Petra S.

Very good presentation!

GR
Gene R.

knowledgeable lecturer

PC
Peter C.

thanks, informative.

MV
Michael V.

timely topic interesting subject

JT
Jeffrey T.

Speaker was clearly very knowledgeable, and the slides contained much useful information as well as cites to other material.

JA
Jeremy A.

Very interesting.

Load More

$59

$ 59 Constitutional Law, Intellectual Property Law, and Marijuana Law In Stock

Accreditation

Get Unlimited Access to Lawline Courses

Unlimited CLE Subscription gives you access to take almost any course from our catalog and earn as much CLE credit as you need.